Home/ALZpath/Lee Honigberg
LH

Lee Honigberg

VP of Research & Development

ALZpath

Therapeutic Areas

ALZpath Pipeline

DrugIndicationPhase
pTau217 AntibodyAlzheimer's disease detectionIVD